关注
Oskari Heikinheimo
Oskari Heikinheimo
在 helsinki.fi 的电子邮件经过验证
标题
引用次数
引用次数
年份
ESHRE guideline: management of women with endometriosis
GAJ Dunselman, N Vermeulen, C Becker, C Calhaz-Jorge, T D'hooghe, ...
Human reproduction 29 (3), 400-412, 2014
27412014
The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions
MG Munro, HOD Critchley, IS Fraser, ...
International Journal of Gynecology & Obstetrics 143 (3), 393-408, 2018
8832018
ESHRE guideline: endometriosis
CM Becker, A Bokor, O Heikinheimo, A Horne, F Jansen, L Kiesel, K King, ...
Human reproduction open 2022 (2), hoac009, 2022
7222022
Age, parity, history of abortion and contraceptive choices affect the risk of repeat abortion
O Heikinheimo, M Gissler, S Suhonen
Contraception 78 (2), 149-154, 2008
2682008
Integrated data analysis reveals uterine leiomyoma subtypes with distinct driver pathways and biomarkers
M Mehine, E Kaasinen, HR Heinonen, N Mäkinen, K Kämpjärvi, ...
Proceedings of the National Academy of Sciences 113 (5), 1315-1320, 2016
2192016
Is teenage pregnancy an obstetric risk in a welfare society? A population-based study in Finland, from 2006 to 2011
S Leppälahti, M Gissler, M Mentula, O Heikinheimo
BMJ open 3 (8), e003225, 2013
2122013
Vascular endothelial growth factor in primate endometrium is regulated by oestrogen-receptor and progesterone-receptor ligands in vivo.
RR Greb, O Heikinheimo, RF Williams, GD Hodgen, AL Goodman
Human reproduction (Oxford, England) 12 (6), 1280-1292, 1997
2061997
The molecular mechanisms of oocyte maturation and early embryonic development are unveiling new insights into reproductive medicine.
O Heikinheimo, WE Gibbons
Molecular Human Reproduction 4 (8), 1998
1561998
Plasma concentrations and receptor binding of RU 486 and its metabolites in humans
H Oskari, K Kimmo, C Horacio, S Irving, L Tapani, L Pekka
Journal of steroid biochemistry 26 (2), 279-284, 1987
1531987
Clinical pharmacokinetics of mifepristone
O Heikinheimo
Clinical pharmacokinetics 33, 7-17, 1997
1521997
Lichen sclerosus and risk of cancer
P Halonen, M Jakobsson, O Heikinheimo, A Riska, M Gissler, E Pukkala
International Journal of Cancer 140 (9), 1998-2002, 2017
1452017
Pharmacokinetics and metabolism of RU 486
P Lähteenmäki, O Heikinheimo, H Croxatto, I Spitz, D Shoupe, ...
Journal of steroid biochemistry 27 (4-6), 859-863, 1987
1371987
Mifepristone induced progesterone withdrawal reveals novel regulatory pathways in human endometrium
RD Catalano, HO Critchley, O Heikinheimo, DT Baird, D Hapangama, ...
Molecular human reproduction 13 (9), 641-654, 2007
1362007
Contraceptive use in the Nordic countries
I Lindh, FE Skjeldestad, K Gemzell‐Danielsson, O Heikinheimo, ...
Acta obstetricia et gynecologica Scandinavica 96 (1), 19-28, 2017
1302017
The pharmacokinetics of mifepristone in humans reveal insights into differential mechanisms of antiprogestin action
O Heikinheimo, R Kekkonen, P Lähteenmäki
Contraception 68 (6), 421-426, 2003
1272003
Risk of gynecologic cancer according to the type of endometriosis
L Saavalainen, H Lassus, A But, A Tiitinen, P Härkki, M Gissler, E Pukkala, ...
Obstetrics & Gynecology 131 (6), 1095-1102, 2018
1262018
Immediate complications after medical compared with surgical termination of pregnancy
M Niinimäki, A Pouta, A Bloigu, M Gissler, E Hemminki, S Suhonen, ...
Obstetrics & Gynecology 114 (4), 795-804, 2009
1252009
Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486
T Luukkainen, O Heikinheimo, M Haukkamaa, P Lähteenmäki
Fertility and sterility 49 (6), 961-963, 1988
1191988
Uterine perforation caused by intrauterine devices: clinical course and treatment
J Kaislasuo, S Suhonen, M Gissler, P Lähteenmäki, O Heikinheimo
Human reproduction 28 (6), 1546-1551, 2013
1172013
Hormonal contraception and mental health: results of a population-based study
E Toffol, O Heikinheimo, P Koponen, R Luoto, T Partonen
Human Reproduction 26 (11), 3085-3093, 2011
1112011
系统目前无法执行此操作,请稍后再试。
文章 1–20